L.R. SHARAPHUTDINOVA, A.R. RAKHMATULLIN, Ph.Ph. MUPHAZALOV, K.Z. BAKHTIYAROVA

Bashkir State Medical University, 3 Lenin St., Ufa, Russian Federation, 450000

Sharaphutdinova L.R. — postgraduate student of the Department of Neurology with courses of neurosurgery and medical genetics, tel. +7-927-337-48-43, e-mail: lya6809@yandex.ru

Rakhmatullin A. R. — postgraduate student of the Department of Neurology with courses of neurosurgery and medical genetics, tel. +7-987-245-70-35, e-mail: airatraxmatullin@rambler.ru

Muphazalov Ph.Ph. — D. Med. Sc., Professor of the Department of X-ray diagnostics and radiotherapy, nuclear medicine and radiotherapy to the degree of Postgraduate Education, tel. +7-905-005-86-25, e-mail: fagimmm@mail.ru

Bakhtiyarova K.Z. — D. Med. Sc., Professor of the Department of Neurology with courses of neurosurgery and medical genetics, tel. +7-917-404-35-41, e-mail: bsmu-neuro@yandex.ru 

11 cases of the association of multiple sclerosis and cancer pathology of various localization (only women) are analyzed in the article. The cases were revealed among 1203 patients registered in the Republican Center of Multiple Sclerosis (Ufa). The prevalence of oncological pathology among female patients with multiple sclerosis in the Republic of Bashkortostan was 966 per 100,000. There were no any differences in clinical features of multiple sclerosis in patients with cancer pathology in comparison with patient without cancer.

Key words: multiple sclerosis, cancer pathology, comorbidity.

REFERENCES

1. Estruch B.C. Cormorbidity in multiple sclerosis and its therapeutic approach. Med Clin (Barc), 2014, vol. 3, no. 143, pp. 13-8.
2. Osipova V.V., Voznesenskaya T.G. Comorbidity of migraine: a review of literature and approaches to the study. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova, 2007, no. 3, pp. 34-38 (in Russ.).
3. Franks A.L. Slansky J.E. Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer. Anticancer Res, 2012, vol. 32, pp. 1119-36.
4. Marrie R.A., Reider N., Cohen J. et al. A systematic review of the incidence and prevalence of cancer in multiple sclerosis. Mult Scler., 2015, vol. 3, no. 21, pp. 294-304.
5. Moreira I., Martins Silva A., Santos E. Multiple sclerosis and extra central nervous system malignancies. Journal of Neurology, 2013, vol. 1, no. 260, pp. 176-177.
6. Midgard R., Glattre E., Gronning M. et al. Multiple sclerosis and cancer in Norway. A retrospective cohort study. Acta Neurol Scand, 1996, vol. 6, no. 6, pp. 411-415.
7. Nielsen N.M., Rostgaard K., Rasmussen S. et al. Cancer risk among patients with multiple sclerosis: a population-based register study. Int J Cancer, 2006, vol. 4, no. 118, pp. 979-984.
8. Sumelahti M.L., Pukkala E., Hakama M. Cancer incidence in multiple sclerosis: a 35-year follow-up. Neuroepidemiology, 2004, Vol. 23, no 5, P. 224-227.
9. Catala-Lopes F., Tobias A. Incidence of breast cancer in women with multiple sclerosis: systematic review and meta-analysis of observational cohort studies. Rev Neurol, 2010, Vol. 51, no 9, P. 513-519.
10. Handel A.E., Ramagopalan S.V. Multiple sclerosis and risk of cancer: a meta-analysis. J Neurol Neurosurg Psychiatry, 2010, Vol. 81, P. 1413-1414.
11. Achiron .A, Barak Y., Gail M. et al. Cancer incidence in multiple sclerosis and effects of immunomodulatory treatments. Breast Cancer Res Treat, 2005, Vol. 89, no 3, P. 265-270.
12. Confavreux C., Saddier P., Grimaud J. et al. Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study. Neurology, 1996, vol. 6, no. 46, pp. 1607-1612.
13. Lebrun C., Vermersch P., Brassat D. et al. Cancer and multiple sclerosis in the era of disease-modifying treatment. J Neurol, 2011, vol. 7, no. 258, pp. 1304-1311.
14. Khasaeva M.A., Gorokhova T.V., Boyko A.N. et al. Alemtuzumab — a new drug based on monoclonal antibodies for the treatment of multiple sclerosis: therapeutic opportunities and risks (review). Rasseyannyy skleroz. Zhurnal nevrologii i psikhiatrii, 2013, vol. 113, no. 2, pp. 87-92 (in Russ.).
15. Boyko A.N., Gusev E.I. Lakvinimod – new tableted preparation with neuroprotective treatment for multiple sclerosis (Review). Zhurnal nevrologii i psikhiatrii, 2013, vol. 113, no. 2, pp. 93-99 (in Russ.).
16. Sirotko M.L., Denisenko M.B. Analysis of the incidence of malignant neoplasms of the population of the Samara region in 2000-2010 gg. and its outlook till 2025. Profilakticheskaya meditsina, 2012, no.1, pp. 20-25 (in Russ.).